Dudediligence.

InMed Pharmaceuticals Inc

INMNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 424B3, ProspectusOct 1 →Insiders6 insiders bought $1.1M in 21 open-market buys. No sales.→HoldersAdar1 15.0%Vivo Capital 15.0%Squadron 6.1%→Financing →PeersClosest companies: MBRX, MDCX, JSPR→

From the filings

Figures

Revenue
$4.5Mlast 12 months
Net income
−$12.6Mlast 12 months
Operating cash flow
−$8.6Mlast 12 months
Cash and equivalents
$2.2Mat the last balance sheet
Shares outstanding
5.3M shareson issue
Every year and quarter →